Literature DB >> 6508522

A proposed classification of intra-abdominal infections. Stratification of etiology and risk for future therapeutic trials.

J L Meakins, J S Solomkin, M D Allo, E P Dellinger, R J Howard, R L Simmons.   

Abstract

Serious studies of ultra-abdominal infections have yielded a mortality that ranges from 3.5% (a composite of antibiotic studies evaluating 1,275 patients) to more than 60% in studies of multiple-organ failure. In reviewing these studies, it is apparent that under the umbrella of "serious intra-abdominal infection," different diseases, processes, and patients are being studied. We define a binomial classification incorporating both an anatomic and a functional approach to intra-abdominal infection. There are ten etiologic classifications of intra-abdominal infections combined with an acute physiologic score (APS), measuring severity of illness, in three gradations. In the patient with undifferentiated intra-abdominal sepsis, the patient will be in class I, II, III, or IV, with a score, A, B, or C, added. Each of the groups V-X, defining a specific infectious category, can also use the APS, which has been verified in patients in intensive care and in those with intra-abdominal infection. It is anticipated that using this approach will provide a technique to evaluate patient groups uniformly in which drug or technical approaches to the management of intra-abdominal infections are being studied. The patients being studied will be more clearly defined, and studies will be comparable from one center to another.

Entities:  

Mesh:

Year:  1984        PMID: 6508522     DOI: 10.1001/archsurg.1984.01390240010002

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  22 in total

1.  Results of a multicenter trial comparing imipenem/cilastatin to tobramycin/clindamycin for intra-abdominal infections.

Authors:  J S Solomkin; E P Dellinger; N V Christou; R W Busuttil
Journal:  Ann Surg       Date:  1990-11       Impact factor: 12.969

Review 2.  Current and future concepts of abdominal sepsis.

Authors:  Klaus Emmanuel; Heike Weighardt; Holger Bartels; Jorg-Rudiger Siewert; Bernhard Holzmann
Journal:  World J Surg       Date:  2005-01       Impact factor: 3.352

3.  Sequential abdominal reexploration with the zipper technique.

Authors:  M A Cuesta; M Doblas; L Castañeda; E Bengoechea
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

Review 4.  Principles and limitations of operative management of intraabdominal infections.

Authors:  E H Farthmann; U Schöffel
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

Review 5.  Management of secondary peritonitis.

Authors:  D H Wittmann; M Schein; R E Condon
Journal:  Ann Surg       Date:  1996-07       Impact factor: 12.969

Review 6.  Imipenem/cilastatin: a pharmacoeconomic appraisal of its use in intra-abdominal infections.

Authors:  P Benfield; P Chrisp
Journal:  Pharmacoeconomics       Date:  1992-06       Impact factor: 4.981

7.  Factors predicting discharge from intensive care: a Canadian experience.

Authors:  M J Girotti; S J Brown
Journal:  Can Anaesth Soc J       Date:  1986-05

Review 8.  Epidemiology and pathophysiology of intraabdominal infections (IAI).

Authors:  E H Farthmann; U Schöffel
Journal:  Infection       Date:  1998 Sep-Oct       Impact factor: 3.553

9.  [Follow-up of infected patients in an intensive care unit using the "infection score," endotoxin and AT III determination].

Authors:  R Grundmann; M Hornung
Journal:  Langenbecks Arch Chir       Date:  1988

10.  Importance of pre-existing co-morbidities for prognosis of septicemia in critically ill patients.

Authors:  D Pittet; B Thiévent; R P Wenzel; N Li; G Gurman; P M Suter
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.